IQV
IQVIA HOLDINGS INC.
NYSE: IQV · Durham, NC · Healthcare
$208.05+0.73 (+0.35%)Closed
Market Cap$34.72B
Cash$2.10Bmost recent
Runwayprofitable
P/E (TTM)26.5EPS $7.84
52-Wk Range$156.66 – $244.29
Avg Volume1.6M3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$208.05-10.4%
Pipeline
Drug candidates sponsored by IQVIA · ClinicalTrials.gov
| Phase | Drug / Candidate | Indications | Status | Next Completion | Trials | |
|---|---|---|---|---|---|---|
| Phase 1 | bacTRL-IL-12 | Cancer - Solid Tumours | Terminated | 2020-12-29past | 1 | |
| N/A | Unnamed | COVID-19 | Completed | 2023-02-23past | 1 |
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for IQV. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.